UpHealth, Inc.
UPH · NYSE
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $32,681 | $37,823 | $42,145 | $40,497 |
| % Growth | -13.6% | -10.3% | 4.1% | – |
| Cost of Goods Sold | $15,058 | $17,847 | $19,469 | $22,282 |
| Gross Profit | $17,623 | $19,976 | $22,676 | $18,215 |
| % Margin | 53.9% | 52.8% | 53.8% | 45% |
| R&D Expenses | $1,978 | $848 | $1,285 | $1,944 |
| G&A Expenses | $9,415 | $13,823 | $11,998 | $13,658 |
| SG&A Expenses | $12,160 | $16,244 | $16,617 | $17,987 |
| Sales & Mktg Exp. | $2,745 | $2,421 | $4,619 | $4,329 |
| Other Operating Expenses | $61,814 | $0 | $1,611 | $2,868 |
| Operating Expenses | $15,966 | $18,828 | $19,513 | $22,799 |
| Operating Income | -$72,789 | -$10,742 | $3,163 | -$4,493 |
| % Margin | -222.7% | -28.4% | 7.5% | -11.1% |
| Other Income/Exp. Net | $52,651 | -$7,010 | -$6,857 | -$5,415 |
| Pre-Tax Income | -$20,138 | -$17,752 | -$7,635 | -$18,822 |
| Tax Expense | $467 | $867 | $448 | $8,360 |
| Net Income | -$20,605 | -$19,127 | -$8,083 | -$27,182 |
| % Margin | -63% | -50.6% | -19.2% | -67.1% |
| EPS | -1.12 | -1.05 | -0.51 | -1.81 |
| % Growth | -6.7% | -105.9% | 71.8% | – |
| EPS Diluted | -1.12 | -1.05 | -0.51 | -1.81 |
| Weighted Avg Shares Out | 18,428 | 18,216 | 15,730 | 15,028 |
| Weighted Avg Shares Out Dil | 18,428 | 18,220 | 15,730 | 15,030 |
| Supplemental Information | – | – | – | – |
| Interest Income | $295 | $155 | $6,858 | $91 |
| Interest Expense | $6,709 | $7,136 | $6,875 | $6,194 |
| Depreciation & Amortization | $3,979 | $3,606 | $2,971 | $5,062 |
| EBITDA | -$9,450 | -$7,010 | $6,134 | $569 |
| % Margin | -28.9% | -18.5% | 14.6% | 1.4% |